000293613 001__ 293613
000293613 005__ 20241204134931.0
000293613 0247_ $$2doi$$a10.1158/1078-0432.CCR-24-2100
000293613 0247_ $$2pmid$$apmid:39320341
000293613 0247_ $$2ISSN$$a1078-0432
000293613 0247_ $$2ISSN$$a1557-3265
000293613 0247_ $$2altmetric$$aaltmetric:168551223
000293613 037__ $$aDKFZ-2024-01929
000293613 041__ $$aEnglish
000293613 082__ $$a610
000293613 1001_ $$00000-0003-1500-9713$$aKalish, Jennifer M$$b0
000293613 245__ $$aUpdate on surveillance for Wilms tumor and hepatoblastoma in Beckwith-Wiedemann Syndrome and other predisposition syndromes.
000293613 260__ $$aPhiladelphia, Pa. [u.a.]$$bAACR$$c2024
000293613 3367_ $$2DRIVER$$aarticle
000293613 3367_ $$2DataCite$$aOutput Types/Journal article
000293613 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1733316549_12765$$xReview Article
000293613 3367_ $$2BibTeX$$aARTICLE
000293613 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000293613 3367_ $$00$$2EndNote$$aJournal Article
000293613 500__ $$a2024 Dec 2;30(23):5260-5269
000293613 520__ $$aWilms tumors are commonly associated with predisposition syndromes many, but not all, of which include overgrowth. Several of these syndromes also include a risk of other embryonal malignancies - particularly hepatoblastoma. Guidelines for surveillance in this population were published in 2017 and recently members of the AACR Pediatric Cancer Working Group met to update those guidelines with a review of more recently published evidence and risk estimates. This perspective serves to update pediatric oncologists, geneticists, radiologists, counselors and other healthcare professionals on revised diagnostic criteria, review previously published surveillance guidelines and harmonize updated surveillance recommendations in the North American and Australian context for patients with overgrowth syndromes and other syndromes associated with Wilms tumor predisposition.
000293613 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000293613 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000293613 7001_ $$00000-0002-1935-5157$$aBecktell, Kerri D$$b1
000293613 7001_ $$00000-0002-1475-0254$$aBougeard, Gaëlle$$b2
000293613 7001_ $$00000-0002-6721-122X$$aBrodeur, Garrett M$$b3
000293613 7001_ $$00000-0002-4073-5509$$aDiller, Lisa R$$b4
000293613 7001_ $$00000-0003-3202-0447$$aDoria, Andrea S$$b5
000293613 7001_ $$00000-0001-7733-383X$$aHansford, Jordan R$$b6
000293613 7001_ $$00000-0001-8634-0388$$aKlein, Steven D$$b7
000293613 7001_ $$00000-0002-9134-9640$$aKohlmann, Wendy K$$b8
000293613 7001_ $$00000-0003-4120-5873$$aKratz, Christian P$$b9
000293613 7001_ $$00000-0001-5894-6403$$aMacFarland, Suzanne P$$b10
000293613 7001_ $$0P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aPajtler, Kristian$$b11$$udkfz
000293613 7001_ $$00000-0001-8333-0758$$aRednam, Surya P$$b12
000293613 7001_ $$00000-0003-2543-8378$$aSchienda, Jaclyn$$b13
000293613 7001_ $$00000-0003-0260-3975$$aStates, Lisa J$$b14
000293613 7001_ $$00000-0003-3283-2197$$aVillani, Anita$$b15
000293613 7001_ $$00000-0002-6501-4150$$aWeksberg, Rosanna$$b16
000293613 7001_ $$00000-0003-0970-1850$$aZelley, Kristin$$b17
000293613 7001_ $$00000-0003-2579-1833$$aTomlinson, Gail E$$b18
000293613 7001_ $$00000-0002-9475-0077$$aBrzezinski, Jack J$$b19
000293613 773__ $$0PERI:(DE-600)2036787-9$$a10.1158/1078-0432.CCR-24-2100$$n23$$p5260-5269$$tClinical cancer research$$v30$$x1078-0432$$y2024
000293613 909CO $$ooai:inrepo02.dkfz.de:293613$$pVDB
000293613 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000293613 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000293613 9141_ $$y2024
000293613 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN CANCER RES : 2022$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-25
000293613 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bCLIN CANCER RES : 2022$$d2023-08-25
000293613 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000293613 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000293613 980__ $$ajournal
000293613 980__ $$aVDB
000293613 980__ $$aI:(DE-He78)B062-20160331
000293613 980__ $$aI:(DE-He78)HD01-20160331
000293613 980__ $$aUNRESTRICTED